Sembcorp share price edges up as Alinta vote nears — what SGX traders watch next
23 January 2026
1 min read

Sembcorp share price edges up as Alinta vote nears — what SGX traders watch next

Singapore, Jan 23, 2026, 15:40 SGT — Regular session

  • Sembcorp Industries shares edged higher by 0.3%, reaching S$5.99 in mid-afternoon trading
  • The shareholder vote tied to the Alinta Energy deal is scheduled for Jan 30 and has drawn intense focus.
  • Key upcoming dates include the proxy deadline on Jan 27, with FY2025 results due by Feb 25

Sembcorp Industries Ltd shares edged up on Friday, bucking the choppy Singapore market. Investors positioned themselves ahead of a shareholder vote on the group’s proposed Alinta Energy deal. The stock ticked up 0.34% to S$5.99, trading within a range of S$5.97 to S$6.05. (Tiger Brokers quote)

The deal now moves into its “administrative” phase as shareholder questions wind down and the proxy deadline approaches next week. On Wednesday, retail investor group SIAS held an online session featuring Sembcorp’s CEO Wong Kim Yin and group CFO Eugene Cheng. (SIAS event page)

The broader market remained firm, lending some support. Singapore’s benchmark Straits Times Index hit a fresh peak on Friday, boosted by record gains in key banks, traders said. (Business Times report)

Risk appetite in the region rose after the Bank of Japan chose to keep rates unchanged, lifting Asian stocks and nudging the yen slightly lower. (Reuters global markets)

Sembcorp faces a crucial test on Jan. 30, with shareholders scheduled to vote on the proposed acquisition at an extraordinary general meeting in Singapore, according to the company’s event notice. (Sembcorp EGM page)

In a December investor presentation, Sembcorp outlined Alinta as a vertically integrated gas and electricity provider in Australia, with 3.4 GW of installed and contracted generation capacity. The acquisition will be supported by a fully committed A$6.5 billion bridge facility, requiring no equity raise. Sembcorp aims to complete the deal in the first half of 2026, subject to shareholder and regulatory approvals. The company also said it will seek clearance from Australia’s FIRB and the ACCC. (SGX presentation)

Traders are watching for responses to shareholder questions ahead of the proxy deadline. These disclosures might ramp up debate over price, leverage, and the refinancing schedule for the bridge funding.

The risks are obvious: shareholders may push back, regulators could stall, and if credit spreads widen, financing might appear less secure. A drop in power prices or tougher scrutiny on transition optics could shake the stock ahead of the vote.

Investors are looking past the EGM, as Sembcorp is scheduled to report its FY2025 results on Feb. 25. This update is expected to shed more light on cash flow and balance-sheet flexibility before the acquisition timeline unfolds. (Sembcorp events calendar)

Stock Market Today

  • Genetic Engineering Tool Market Set to Reach $28.57 Billion by 2031 Driven by CRISPR Advances
    January 23, 2026, 6:51 AM EST. The Global Genetic Engineering Tool Market is forecast to grow at a 4.38% CAGR, expanding from $22.09 billion in 2025 to $28.57 billion by 2031. Key growth drivers include rapid technological progress in genome editing platforms like CRISPR-Cas9, which is transitioning from lab research to clinically approved therapies. Notably, the FDA's approval of CASGEVY underscores the commercial viability of gene-edited treatments. Increased funding in biotech and genomics fuels demand for advanced tools and instrumentation. However, stringent regulatory frameworks and ethical concerns over off-target effects delay clinical advances, hindering the shift to large-scale commercial tool procurement. Despite robust investment and nine new product approvals reported in 2024, regulatory hurdles remain a critical challenge for market expansion.
ST Engineering stock price dips in Singapore as LOT Dreamliner deal, OCBC target hike steer focus to Feb results
Previous Story

ST Engineering stock price dips in Singapore as LOT Dreamliner deal, OCBC target hike steer focus to Feb results

Genting Singapore stock slips as STI hits record — what investors watch next
Next Story

Genting Singapore stock slips as STI hits record — what investors watch next

Go toTop